⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
Lilly's Jaypirca (pirtobrutinib), the first and only approved non-covalent (reversible) BTK inhibitor, significantly improved progression-free survival in patients with treatment-naïve CLL/SLL
prnewswire.com
LLY
Lilly's oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity
prnewswire.com
LLY
Lilly to participate in Morgan Stanley 23rd Annual Global Healthcare Conference
prnewswire.com
LLY
Lilly to participate in Wells Fargo 20th Annual Healthcare Conference
prnewswire.com
LLY
LUNGevity Foundation Unites Communities to Advance Progress During 2026 Lung Cancer Awareness Month
prnewswire.com
AZN
JNJ
AMGN
LLY
MRK
REGN
JAK Inhibitors Market to Register Notable Growth During the Forecast Period (2026-2036) Through Expanding Clinical and Commercial Landscape | DelveInsight
prnewswire.com
INCY
PRTH
BHC
ACRS
PFE
AMGN
BMY
VERU
LLY
MRK
ABBV
Lilly declares fourth-quarter 2026 dividend
prnewswire.com
LLY
EZRA, the coaching arm of the Adecco Group, launches Loop - the first connected human and AI coaching experience
prnewswire.com
MSFT
SPOT
MA
HSBC
LLY
NOW
EZRA, the coaching arm of the Adecco Group, launches Loop - the first connected human and AI coaching experience
prnewswire.com
MSFT
MA
LLY
NOW
EZRA, la división de coaching de Adecco Group, lanza Loop
prnewswire.com
MSFT
SPOT
MA
HSBC
LLY
NOW